- Home
- PXLW vs LVTX Comparison
PXLW vs LVTX Comparison
Compare PXLW & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXLW
- LVTX
- Stock Information
- Founded
- PXLW 1997
- LVTX 2016
- Country
- PXLW United States
- LVTX Netherlands
- Employees
- PXLW N/A
- LVTX N/A
- Industry
- PXLW Semiconductors
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PXLW Technology
- LVTX Health Care
- Exchange
- PXLW Nasdaq
- LVTX Nasdaq
- Market Cap
- PXLW 50.2M
- LVTX 41.3M
- IPO Year
- PXLW 2000
- LVTX 2021
- Fundamental
- Price
- PXLW $10.28
- LVTX $1.54
- Analyst Decision
- PXLW Strong Buy
- LVTX Hold
- Analyst Count
- PXLW 3
- LVTX 4
- Target Price
- PXLW $13.67
- LVTX $1.58
- AVG Volume (30 Days)
- PXLW 162.2K
- LVTX 111.8K
- Earning Date
- PXLW 11-11-2025
- LVTX 08-13-2025
- Dividend Yield
- PXLW N/A
- LVTX N/A
- EPS Growth
- PXLW N/A
- LVTX N/A
- EPS
- PXLW N/A
- LVTX N/A
- Revenue
- PXLW $33,961,000.00
- LVTX $4,990,000.00
- Revenue This Year
- PXLW N/A
- LVTX N/A
- Revenue Next Year
- PXLW $25.33
- LVTX N/A
- P/E Ratio
- PXLW N/A
- LVTX N/A
- Revenue Growth
- PXLW N/A
- LVTX N/A
- 52 Week Low
- PXLW $4.67
- LVTX $0.85
- 52 Week High
- PXLW $15.03
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- PXLW 53.16
- LVTX 51.06
- Support Level
- PXLW $7.97
- LVTX $1.53
- Resistance Level
- PXLW $13.50
- LVTX $1.58
- Average True Range (ATR)
- PXLW 1.32
- LVTX 0.03
- MACD
- PXLW 0.31
- LVTX -0.01
- Stochastic Oscillator
- PXLW 43.90
- LVTX 35.71
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.